E-Power Inc. enters the week defined by a single headline: a $252 million microgrid construction deal that would grow the company's power capacity from 3 megawatts to 50 megawatts — yet the stock fell 4.2% on Wednesday, closing at $0.7427.
The deal is the clearest signal worth watching. Announced on May 6, the three-phase microgrid construction and services agreement with ZL Bio targets a 16x capacity expansion. For a micro-cap company with a market cap just under $24 million, the contract value dwarfs the entire enterprise. That mismatch — a $252M contract on a $24M company — explains why the stock appeared in the "industrials stocks moving in after-market" roundups rather than triggering a decisive directional move. The market has not yet resolved what to make of the size of the announcement relative to EPOW's existing scale.
The short-selling picture reinforces the idea that near-term pressure has been fading. Short interest fell 75% over the past month — from roughly 128,000 shares short in early April to just 31,700 now, a fraction of the float at only 0.13% of free float. That level is too low to drive any meaningful short-squeeze dynamic or borrow-market stress. Borrowing costs have eased to 6.6%, down about 4% on the week. Availability is extraordinarily loose at over 2,400% — meaning the lending pool holds more than 24 shares available for every one currently borrowed. There is no pressure building from the short side.
Ownership is heavily concentrated. EPOW's top two holders — Haiping Hu with 22.3% and Yong Rong (HK) Asset Management with 18.1% — together account for over 40% of shares. Two institutional names worth noting added fresh positions at year-end 2025: Two Sigma (67,304 shares) and Citadel Advisors (63,175 shares). Both are quant-driven shops, and their entries are small relative to the float, but the fact that two systematic funds took stakes in the same quarter is a data point worth flagging on a name this thinly covered.
Past earnings events have been modestly negative on balance. The January 2026 print delivered a 4.4% drop on the day, extending to -4.8% after five days. The December 2025 announcement triggered a sharper -9.3% one-day move that deepened to -15.6% over the subsequent week. The sole positive reaction in the history was May 2025, when the stock rose 6.6% on the day and 11% over five sessions. The next earnings event is scheduled for May 15 — nine days away.
The ORTEX short score of 32.8 sits comfortably below mid-range, with no meaningful drift higher over the past two weeks. What to watch heading into the May 15 earnings is less about short positioning — it has already unwound — and more about whether management frames the ZL Bio microgrid contract with enough financial detail to justify a sustained re-rating of a stock that, even after the announcement, is still down 11% over the past month.
See the live data behind this article on ORTEX.
Open EPOW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
